News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

American CryoStem Corporation And Rutgers University File Joint Patent On Adipose-Derived Stem Cell Platform Technology


4/10/2014 7:43:52 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EATONTOWN, N.J., April 10, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a biotechnology developer, marketer and licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has filed its first jointly-owned patent application with its research partners at Rutgers University titled, "Nanoparticle-Mediated Synthetic Transcription Factor for Enhanced Gene Regulation and Cell Differentiation."

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES